Search Results

The American Cancer Society and the American Society of Clinical Oncology announced an expanded collaboration to make it simpler for patients to find authoritative cancer information online.

Mural Oncology plc, a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, shared data from ARTISTRY-3, a clinical trial designed to evaluate the effects of less frequent intravenous dosing of nemvaleukin alfa, in advance of the American Society of Clinical Oncology annual meeting taking place May 31-June 4 in Chicago.

PreciseDx today announced its attendance and participation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL.

Eikon Therapeutics Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.

Replimune Group Inc. announced multiple presentations at the 2024 American Society of Clinical Oncology Annual Meeting being held in Chicago from May 31-June 4, 2024.

Invivyd, Inc. announced that it will present preliminary, subset analyses from the CANOPY Phase 3 clinical trial of VYD222 for pre-exposure prophylaxis of COVID-19 at the 2024 American Society of Clinical Oncology Annual Meeting and at the 2024 American Transplant Congress.

Lipella Pharmaceuticals Inc. announces an abstract publication at the 2024 American Society of Clinical Oncology annual meeting, taking place from May 31 - June 4 in Chicago, IL, and online.

Apollomics Inc., a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, announced a poster presentation and an oral presentation by partner company, Avistone Biotechnology, at the 2024 American Society of Clinical Oncology Annual Meeting, being held May 31-June 4, 2024, in Chicago, Ill. and virtually.

Mural Oncology plc (Nasdaq: MURA) today announced an upcoming poster presentation at the American Society of Clinical Oncology (ASCO) annual meeting taking place May 31-June 4 in Chicago.

Bio-Path Holdings, Inc. announced an upcoming oral presentation at the American Society of Clinical Oncology Annual Meeting, taking place May 31 - June 4, 2024 in Chicago, IL.